Logo

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Ce...

HOUSTON, May 22, 2020 /PRNewswire-AsiaNet/ -- -- PneumoBlast(TM) Reduces Pathology and Lung Fluid Accumulation inModel of COVID-19FibroGenesis announced today significant efficacy of its PneumoBlast(TM) product in an animal model of lung inflammation which resembles COVID-19.M...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660